Nerve gas terrorism: A grim challenge to anesthesiologists

Anesthesia and Analgesia

Volumn 96, Issue 3, 2003, Pages 819-825

  De Jong, Rudolph H ^a,b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDOTE; ATROPINE; BENZODIAZEPINE DERIVATIVE; CHOLINESTERASE INHIBITOR; DIAZEPAM; HOMATROPINE; MIDAZOLAM; NERVE GAS; PRALIDOXIME; VOLATILE AGENT;

ANESTHESIST; ANTHRAX; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL SPORE; BIOLOGICAL WARFARE; BLADDER DYSFUNCTION; BRADYCARDIA; BRONCHOSPASM; CAUSE OF DEATH; CHEMICAL WARFARE; CLINICAL FEATURE; CONVALESCENCE; CONVULSION; DEHYDRATION; DISEASE SEVERITY; EMERGENCY HEALTH SERVICE; EMERGENCY TREATMENT; ENVIRONMENTAL EXPOSURE; EYE PAIN; FASCICULATION; HISTORY; HOSPITAL ADMISSION; HUMAN; HYPERTHERMIA; INHALATION; INTENSIVE CARE; INTESTINE MOTILITY; INTOXICATION; LETHAL DOSE; MIOSIS; MYDRIASIS; PHOTOPHOBIA; PRIORITY JOURNAL; RESCUE PERSONNEL; RESPIRATION DEPRESSION; RHINORRHEA; ROOM TEMPERATURE; SKIN TOXICITY; TACHYCARDIA; TERRORISM; VAPORIZATION; WHEEZING;

ANESTHESIOLOGY; CHEMICAL WARFARE AGENTS; CHOLINESTERASE INHIBITORS; DISASTER PLANNING; GASES; HUMANS; ORGANOTHIOPHOSPHORUS COMPOUNDS; RESCUE WORK; TERRORISM; TRIAGE;

EID: 0037369612     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Smart JK. History of chemical and biological warfare: an American perspective. In: Zajtchuk R, Bellamy RF, eds. Textbook of military medicine. Vol. 1. Falls Church, VA: Office of the Surgeon General (Department of the Army), 1997:9-17.
2. Gilmore JS. Presidential advisory panel to assess domestic response capabilities for terrorism involving weapons of mass destruction ("The Gilmore Commission"): first annual report. I. Assessing the threat. Rand Corp, 1999:123. Available at: http:// www.rand.org/nsrd/terrpanel.
3. Stock T, Haug M, Radler P. Chemical and biological weapon developments and arms control. In: Stockholm international peace research institute yearbook 1996. London: Oxford University Press, 1997:661-708.
4. Taylor P. Anticholinesterase agents. In: Hardman JG, Limbird LE, Gilman AG, eds. Goodman & Gilman's the pharmacological basis of therapeutics. 10th ed. New York: McGraw-Hill, 2001: 175-91.
5. Chemical Casualty Care Division (USAMRICD). MMCC supplemental training materials. ver 2.00. NTIS Product No. AVA20829CDRM [CD-ROM]. Springfield, VA: National Technical Information Service, 2000. Available at: http://www. fedworld.gov/onow.
6. Brennan RJ, Waeckerle JF, Sharp TW, Lillibridge SR. Chemical warfare agents: emergency medical and emergency public health issues. Ann Emerg Med 1999;34:191-204.
7. Waeckerle JF. Domestic preparedness for events involving weapons of mass destruction. JAMA 2000;283:252-4.
8. Quad-Service Field Manual. Nerve agents. In: Treatment of chemical agent casualties and conventional military chemical injuries: FM 8-285/NAVMED P-5041/ AFJMAN 44-149/ FMFM 11-11. Washington, DC: Departments of the Army, Navy, and Air Force, and Commandant Marine Corps. Department of Defense, 1995:2-1 to 2-18). Available at: http:// www.vrkh.org/FM8285/cover.html.
9. Sidell FR. Nerve agents. In: Zajtchuk R, Bellamy RF, eds. Textbook of military medicine. Vol 1. Falls Church, VA: Office of the Surgeon General (Department of the Army), 1997:129-79.
10. Munro NB, Ambrose KR, Watson AP. Toxicity of the organophosphate chemical warfare agents GA, GB, and VX: implications for public protection [review]. Envir Health Perspect 1994; 102:18-38.
11. Holstege CP, Kirk M, Sidell FR. Chemical warfare: nerve agent poisoning. Crit Care Clin 1997;13:923-42.
12. Nozaki H, Aikawa N, Fujishima S, et al. A case of VX poisoning and the difference from sarin. Lancet 1995;346:698-9.
13. de Jong RH. Chemical injury. In: Bowen TE, Bellamy RF, eds. NATO handbook of emergency war surgery. Washington, DC: Second United States Revision, US Department of Defense, 1988:83-94. Available at: http://www.wxh.org/EWSurg/ch06/ 06ChemicalInjury.html.
14. Augustinsson KB. A titrimetric method for the determination of plasma and red blood cell cholinesterase activity using thiocholine esters as substrates. Scand J Clin Lab Invest 1995;7:284-90. Available at: http://chemdef.apgea.army.mil/TBMed296/chap03.asp.
15. Chemical Casualty Care Division (USAMRICD). Medical management of chemical casualties handbook. 3rd ed. Abingdon, MD: EAI Corp, 2000 (290 pages).
16. Kulling P. The terrorist attack with sarin in Tokyo on March 20, 1995. KOMEDA report no. 71. Modin-Tryck, Stockholm, Sweden: Swedish National Board of Health and Welfare, 1998 (68 pages). English summary available at http://www.sos.se/ sos/publ/refereng/9803020e.html.
17. Okumura T, Suzuki K, Fukuda A, et al. The Tokyo subway sarin attack: disaster management. Acad Emerg Med 1998;5:613-28.
18. Abraham RB, Rudick V, Weinbroum AA. Practical guidelines for acute care of victims of bioterrorism: conventional injuries and concomitant nerve agent intoxication [review]. Anesthesiology 2002;97:989-1004.
19. Nozaki H, Hori S, Shinozawa Y, et al. Secondary exposure of medical staff to sarin vapor in the emergency room. Intensive Care Med 1995;21:1032-5.
20. Nakajima T, Sato S. Sarin poisoning of a rescue team in the Matsumoto sarin incident in Japan. Occup Environ Med 1997; 54:697-701.
21. de Jong RH, Quebbeman HJ. Ventilation of the apneic chemical casualty. J US Army Med Department, 1990:PB 8-90-6/7:13-6.
22. Macintyre AG, Christopher GW, Eitzen E, et al. Weapons of mass destruction events with contaminated casualties: effective planning for health care facilities. JAMA 2000;283:242-9.
23. Okumura T, Takasu N, Ishimatsu S, et al. Report on 640 victims of the Tokyo subway sarin attack. Ann Emerg Med 1996;28: 129-35.
24. Suzuki T, Kohno T. Eighteen cases exposed to sarin in Matsumoto, Japan. Intern Med 1997;36:466-70.
25. Nozaki H, Hori S, Shinozawa Y, et al. Relationship between pupil size and acetylcholinesterase activity in patients exposed to sarin vapor. Intensive Care Med 1997;23:1005-7.
26. Oberst FW, Koon WS, Christensen MK, et al. Retention of inhaled sarin vapor and its effect on red blood cell cholinesterase activity in man. Clin Pharmacol Ther 1968;9:421-7.
27. Nakajima T, Ohta S, Morita H, et al. Epidemiologic study of sarin poisoning in Matsumoto City, Japan. J Epidemiol 1998;8: 33-41.
28. Suzuki T, Morita H, Ono K, et al. Sarin poisoning in Tokyo subway. Lancet 1995;345:980.
29. Ohbu S, Yamashina A, Nobukatsu T, et al. Sarin poisoning on Tokyo subway. South Med J 1997;90:587-93.